Berobenatide
VESPER-4
Pfizer · Phase 3 · Active, not recruiting · Enrollment 3578
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| MET097 Dose 1 | Obesity or overweight | n/r | 84 | n/r | n/r |
| MET097 Dose 2 | Obesity or overweight | n/r | 84 | n/r | n/r |
| MET097 Dose 3 | Obesity or overweight | n/r | 84 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 84 | n/r | n/r |